TLG-001J Confirmatory Clinical Trial

INTERVENTION: The subjects will be assigned randomly to the trial device or control device at a 1:1 ratio and wear the assigned device every day for 12 months. This will be followed by 12‐month follow‐up period without wearing the device. There will be 9 visits in total during these 24 months. CONDITION: Myopia PRIMARY OUTCOME: Change from baseline in cycloplegic objective refraction: SE at Month 12 of investigational device use SECONDARY OUTCOME: Changes from baseline in axial length at Months 1, 3, 6, 9, and 12 of device use, and others INCLUSION CRITERIA: ‐ Male and female Japanese schoolchildren who are 6 to 12 years old at the time of informed consent ‐ Anisometropia is within 1.50 D ‐ Astigmatism, cycloplegic objective refraction (C), is within +/‐ 1.50 D for each eye